Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Abgottspon

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Chimia|May 23, 2012
In vivo evaluation of FimH antagonists - a novel class of antimicrobials for the treatment of urinary tract infectionDaniela Abgottspon, Beat Ernst
Assay and Drug Development Technologies|June 17, 2011
A flow cytometry-based assay for screening FimH antagonistsMeike Scharenberg, Daniela Abgottspon, Evelin Cicek, et al.
Journal of Medicinal Chemistry|April 24, 2012
Antiadhesion therapy for urinary tract infections--a balanced PK/PD profile proved to be key for successXiaohua Jiang, Daniela Abgottspon, Simon Kleeb, et al.
Chembiochem : a European Journal of Chemical Biology|March 19, 2016
The Conformational Variability of FimH: Which Conformation Represents the Therapeutic Target?Deniz Eris, Roland C Preston, Meike Scharenberg, et al.
Bioorganic & Medicinal Chemistry|October 4, 2011
Design, synthesis and biological evaluation of mannosyl triazoles as FimH antagonistsOliver Schwardt, Said Rabbani, Margrit Hartmann, et al.
Journal of Microbiological Methods|July 13, 2010
Development of an aggregation assay to screen FimH antagonistsDaniela Abgottspon, Gina Rölli, Lucie Hosch, et al.
Journal of Medicinal Chemistry|November 26, 2010
FimH antagonists for the oral treatment of urinary tract infections: from design and synthesis to in vitro and in vivo evaluationTobias Klein, Daniela Abgottspon, Matthias Wittwer, et al.
Journal of Medicinal Chemistry|February 11, 2015
FimH antagonists: bioisosteres to improve the in vitro and in vivo PK/PD profileSimon Kleeb, Lijuan Pang, Katharina Mayer, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Chimia|May 23, 2012
In vivo evaluation of FimH antagonists - a novel class of antimicrobials for the treatment of urinary tract infectionDaniela Abgottspon, Beat Ernst
Assay and Drug Development Technologies|June 17, 2011
A flow cytometry-based assay for screening FimH antagonistsMeike Scharenberg, Daniela Abgottspon, Evelin Cicek, et al.
Journal of Medicinal Chemistry|April 24, 2012
Antiadhesion therapy for urinary tract infections--a balanced PK/PD profile proved to be key for successXiaohua Jiang, Daniela Abgottspon, Simon Kleeb, et al.
Chembiochem : a European Journal of Chemical Biology|March 19, 2016
The Conformational Variability of FimH: Which Conformation Represents the Therapeutic Target?Deniz Eris, Roland C Preston, Meike Scharenberg, et al.
Bioorganic & Medicinal Chemistry|October 4, 2011
Design, synthesis and biological evaluation of mannosyl triazoles as FimH antagonistsOliver Schwardt, Said Rabbani, Margrit Hartmann, et al.
Journal of Microbiological Methods|July 13, 2010
Development of an aggregation assay to screen FimH antagonistsDaniela Abgottspon, Gina Rölli, Lucie Hosch, et al.
Journal of Medicinal Chemistry|November 26, 2010
FimH antagonists for the oral treatment of urinary tract infections: from design and synthesis to in vitro and in vivo evaluationTobias Klein, Daniela Abgottspon, Matthias Wittwer, et al.
Journal of Medicinal Chemistry|February 11, 2015
FimH antagonists: bioisosteres to improve the in vitro and in vivo PK/PD profileSimon Kleeb, Lijuan Pang, Katharina Mayer, et al.
Pageof 1